Investors Towarzystwo Funduszy Inwestycyjnych Spolka Akcyjna’s Idexx Laboratories IDXX Stock Holding History

Investors Towarzystwo Funduszy Inwestycyjnych Spolka Akcyjna’s Portfolio IDXX Stock Details IDXX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-800	Closed	-$402K	–	162
2023 Q2	$402K	Hold	800	–	–	0.19%	78
2023 Q1	$395K	Hold	800	–	–	0.23%	72
2022 Q4	$326K	Buy	800 +60	+8%	+$23.3K	0.25%	59
2022 Q3	$241K	Buy	+740	New	+$272K	0.2%	48

Other funds holding IDXX

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

Fundsmith LLP London, United Kingdom $12.8B AUM 6.9% 1-Year Est. Return

BAMCO Inc New York $33.1B AUM 11.16% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

William Blair & Company Chicago, Illinois $38.4B AUM 25.71% 1-Year Est. Return

Investors Towarzystwo Funduszy Inwestycyjnych Spolka Akcyjna's IDXX Position: Q3 2023 in Review

Investors Towarzystwo Funduszy Inwestycyjnych Spolka Akcyjna sold out of Idexx Laboratories (IDXX) in Q3 2023, closing a stake of 800 shares — an estimated $402K sold.

Investors Towarzystwo Funduszy Inwestycyjnych Spolka Akcyjna first reported a position in IDXX in Q3 2022 and held it in 4 quarters. The position peaked at $402K in Q2 2023. 1,060 funds tracked by Wall St. Rank hold IDXX as of Q3 2023.

Investors Towarzystwo Funduszy Inwestycyjnych Spolka Akcyjna reported no remaining Idexx Laboratories position as of Q3 2023 after selling out during the quarter.
Investors Towarzystwo Funduszy Inwestycyjnych Spolka Akcyjna sold 800 Idexx Laboratories shares in Q3 2023, an estimated $402K.
Investors Towarzystwo Funduszy Inwestycyjnych Spolka Akcyjna first reported a position in Idexx Laboratories in Q3 2022 and held it in 4 quarters.
Investors Towarzystwo Funduszy Inwestycyjnych Spolka Akcyjna's Idexx Laboratories position peaked at $402K in Q2 2023.
1,060 funds tracked by Wall St. Rank held Idexx Laboratories as of Q3 2023.

Based on Investors Towarzystwo Funduszy Inwestycyjnych Spolka Akcyjna's 13F filing for Q3 2023, filed 2 Sep 2025.